DEF: Sabra Health Care REIT Announces 2025 Annual Meeting of Stockholders

Sabra Health Care REIT will hold its 2025 Annual Meeting of Stockholders on June 12, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.

Summary

• Sabra Health Care REIT, Inc. will hold its 2025 Annual Meeting of Stockholders on June 12, 2025, at its headquarters in Tustin, California.
• Stockholders of record as of April 15, 2025, are entitled to vote.
• The meeting will address the election of seven directors, ratification of PricewaterhouseCoopers LLP as the independent accounting firm for the fiscal year ending December 31, 2025, and an advisory vote on executive compensation.
• The Board of Directors recommends voting FOR all director nominees, FOR the ratification of PricewaterhouseCoopers LLP, and FOR the advisory approval of executive compensation.
• As of March 31, 2025, there were 237,936,460 shares of common stock outstanding and eligible to vote.
• The Board of Directors has determined that none of Messrs. Barbarosh, Foster, Malehorn or Porter nor Mses. Cusack, Katzmann or Kono has a relationship that, in the opinion of the Board of Directors, would interfere with the directors exercise of independent judgment in carrying out his or her responsibilities as a director and that each such director is an independent director under the Nasdaq rules.

Sentiment

Score: 7

Explanation: The document is neutral in tone, providing necessary information for the upcoming shareholder meeting. It focuses on standard corporate governance procedures and proposals.

Positives

• The Board of Directors is actively engaged with stockholders to receive their feedback.
• The company has a highly independent board and fully independent committees.
• The company has policies and practices to align executive compensation with long-term stockholder interests.
• The company has a comprehensive new director orientation process.
• The company has annual review of CEO and management succession plans.
• The company has a commitment to consider qualified female and minority director candidates.
• The company has robust stock ownership requirements for executives and directors.
• The company has anti-hedging and anti-pledging policies.
• The company has an independent board committee oversight of cybersecurity risks, human capital and environmental, social and governance matters.
• The company has regular and proactive board and management succession planning.

Future Outlook

The document outlines proposals for the 2025 Annual Meeting, indicating a focus on governance and operational continuity.

Industry Context

This is a standard proxy statement related to corporate governance matters, typical for publicly traded REITs.

Stakeholder Impact

• Shareholders are asked to vote on key company decisions.
• The outcome of the votes will influence the direction and oversight of the company.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the Annual Meeting on June 12, 2025, or submit a proxy in advance.

Key Dates

Keywords

proxy statement, annual meeting, stockholders, board of directors, executive compensation, director election, PricewaterhouseCoopers, corporate governance, Sabra Health Care REIT, REIT